CSF α-synuclein seed amplification assays detect Lewy body pathology accurately but are invasive and costly. Here, the authors show that a two-step workflow using smell-function prescreening maintained 94% accuracy while reducing CSF testing by 43%.
- Sophie E. Mastenbroek
- Lyduine E. Collij
- Oskar Hansson
